Long-Term Safety and Efficacy of Tralokinumab in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis Treated for up to 6 Years. (2025). SKIN The Journal of Cutaneous Medicine, 9(2), s573. https://doi.org/10.25251/skin.10.supp.573